Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders

European Journal of Medicinal Chemistry 2026

View at publisher
Authors: Seyed Ebrahim Alavi, Reza Boshrouyeh, Aun Raza, Hasan Ebrahimi Shahmabadi
DOI: 10.1016/j.ejmech.2026.118587
Cited by: 4
References: 94

Fields of Study & Subjects

Diabetes Treatment and Management Bariatric Surgery and Outcomes Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Volume
305
Pages
118587–118587
Publication date
14 January 2026
Language
EN